SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891836-01-500169
Filing Date
2001-07-11
Accepted
2001-07-11 00:00:00
Documents
2
Group Members
ANDREW H. TISCHDANIEL R. TISCHFELIX J. BAKERJAMES S. TISCHJULIAN C. BAKERTHOMAS J. TISCHTISCH THOMAS J

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D sc300536.htm SC 13D/A 38667
2 EXHIBIT 5: JOINT FILING AGREEMENT sc0084-01b.htm EX-99.5 1567
  Complete submission text file 0000891836-01-500169.txt   42590
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45279 | Film No.: 1678716
SIC: 2834 Pharmaceutical Preparations

Mailing Address 667 MADISON AVE NEW YORK NY 10021
Business Address C/O B.L. BLOOM 667 MADISON AVENUE NEW YORK NY 10021 212-545-2930
TISCH THOMAS J (Filed by) CIK: 0001081916 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231